Announcements Trials
Browse Landscape

Status

Active not recruiting 3Completed 2

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Prostatic Neoplasms 1Pheochromocytoma 1Hyperaldosteronism 1Endocrine Gland Neoplasms 1Colorectal Neoplasms 1ACTH Syndrome, Ectopic 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Staining and Labeling × Clear all
NCT07597369 2026-05-19

Clinically Actionable Tumor-Associated Antigens in Prostate Cancer

Peking University First Hospital

Active not recruiting
1,600 enrolled
Genitourinary

Prostatic Neoplasms

NCT07564908 2026-05-04

CRLM

West China Hospital

Active not recruiting
64 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05446779 2024-04-16

SuddenDeath

Helsinki University Central Hospital

Active not recruiting
400 enrolled
Endocrine

ACTH Syndrome, Ectopic, Endocrine Gland Neoplasms, Hyperaldosteronism, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡